Form 8-K · Current Report · Filed 2026-06-03
IQVIA Inc. Announces €950M Senior Notes Offering
On June 3, 2026, IQVIA Holdings Inc. announced through its subsidiary, IQVIA Inc., its intention to raise €950,000,000 through an offering of senior notes due 2033. The proceeds will be used to refinance existing indebtedness and cover offering-related fees and expenses. The offering is subject to market and customary conditions. The notes have not been registered under the Securities Act of 1933 and may not be offered or sold in the U.S. without registration or an exemption.
- Filer
- Iqvia Holdings Inc. IQV · NYSE
- Filed
- Accession
- 0001193125-26-255635
- CIK
- 0001478242
- Signal
- Medium impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Reported Item
Market reaction
Close before filing
$180.64
Next session
+3.5%
Since filing
+30.1%
Latest close
$235.02
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from IQV reporting the same item, with the next session's move:
Insider tape
Within 45 days of this filing, IQV insiders reported 8 Form 4 transactions — net buying of $285K.
About Iqvia Holdings Inc.
Iqvia Holdings Inc. is a leading global provider of advanced analytics, technology solutions, and contract research services. Its primary function is to support the healthcare sector by offering data-driven insights and innovations that underpin strategic decision-making across pharmaceutical, biotechnology, and medical device industries. Iqvia plays a crucial role in facilitating drug development through its comprehensive clinical research capabilities, encompassing everything from clinical trials to regulatory submissions. Additionally, its technology solutions leverage artificial intelligence and machine learning to optimize clinical and commercial operations, contributing to enhanced patient outcomes and streamlined healthcare delivery. Iqvia's integrated services impact sectors such as drug safety, patient engagement, and real-world evidence, making it an indispensable partner for healthcare companies seeking to navigate complex markets and regulatory environments. Globally recognized for its vast data repository and cutting-edge analytical platforms, Iqvia serves as a pivotal player in the transformation of the healthcare landscape, empowering organizations to accelerate innovation and improve patient care.
Never miss another IQV filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.